Diagnostic reproducibility of hydatidiform moles: Ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis

American Journal of Surgical Pathology

Volumn 36, Issue 3, 2012, Pages 443-453

  Vang, Russell ^a,b   Gupta, Mamta ^a   Wu, Lee Shu Fune ^c   Yemelyanova, Anna V ^a   Kurman, Robert J ^a,b   Murphy, Kathleen M ^a   Descipio, Cheryl ^a,b   Ronnett, Brigitte M ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

hydatidiform mole; molecular genotyping; p57; reproducibility

Indexed keywords

CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1C; TUMOR MARKER;

ARTICLE; CHEMISTRY; CLASSIFICATION; FEMALE; GENETICS; HUMAN; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PREGNANCY; PROGNOSIS; PROSPECTIVE STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

CYCLIN-DEPENDENT KINASE INHIBITOR P57; FEMALE; HUMANS; HYDATIDIFORM MOLE; IMMUNOHISTOCHEMISTRY; OBSERVER VARIATION; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PREGNANCY; PROGNOSIS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; UTERINE NEOPLASMS;

EID: 84857658202     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31823b13fe     Document Type: Article

References (62)

1. Ambani LM, Vaidya RA, Rao CS, et al. Familial occurrence of trophoblastic disease-report of recurrent molar pregnancies in sisters in three families. Clin Genet. 1980;18:27-29.
2. Bell KA, Van Deerlin V, Addya K, et al. Molecular genetic testing from paraffin-embedded tissue distinguishes nonmolar hydropic abortion from hydatidiform mole. Mol Diagn. 1999;4:11-19.
3. Bifulco C, Johnson C, Hao L, et al. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol. 2008;32:445-451.
4. Castrillon DH, Sun D, Weremowicz S, et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol. 2001;25:1225-1230.
5. Cheung AN, Khoo US, Lai CY, et al. Metastatic trophoblastic disease after an initial diagnosis of partial hydatidiform mole: genotyping and chromosome in situ hybridization analysis. Cancer. 2004;100:1411-1417.
6. Cheville JC, Greiner T, Robinson RA, et al. Ploidy analysis by flow cytometry and fluorescence in situ hybridization in hydropic placentas and gestational trophoblastic disease. Hum Pathol. 1995;26:753-757.
7. Chew SH, Perlman EJ, Williams R, et al. Morphology and DNA content analysis in the evaluation of first trimester placentas for partial hydatidiform mole (PHM). Hum Pathol. 2000;31:914-924.
8. Chiang S, Fazlollahi L, Nguyen A, et al. Diagnosis of hydatidiform moles by polymorphic deletion probe fluorescence in situ hybridization. J Mol Diagn. 2011;13:406-415.
9. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998;78:269-276.
10. Choi-Hong SR, Genest DR, Crum CP, et al. Twin pregnancies with complete hydatidiform mole and coexisting fetus: use of fluorescent in situ hybridization to evaluate placental X-and Y-chromosomal content. Hum Pathol. 1995;26:1175-1180.
11. Conran RM, Hitchcock CL, Popek EJ, et al. Diagnostic considerations in molar gestations. Hum Pathol. 1993;24:41-48.
12. Crisp H, Burton JL, Stewart R, et al. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry. Histopathology. 2003;43:363-373.
13. DeScipio C, Haley L, Beierl K, et al. Diandric triploid hydatidiform mole with loss of maternal chromosome 11. Am J Surg Pathol. 2011;35:1586-1591.
14. El-Maarri O, Seoud M, Riviere JB, et al. Patients with familial biparental hydatidiform moles have normal methylation at imprinted genes. Eur J Hum Genet. 2005;13:486-490.
15. Feltmate CM, Growdon WB, Wolfberg AJ, et al. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med. 2006;51:902-906.
16. Fisher RA, Hodges MD, Newlands ES. Familial recurrent hydatidiform mole: a review. J Reprod Med. 2004;49:595-601.
17. Fisher RA, Khatoon R, Paradinas FJ, et al. Repetitive complete hydatidiform mole can be biparental in origin and either male or female. Hum Reprod. 2000;15:594-598.
18. Fisher RA, Nucci MR, Thaker HM, et al. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol. 2004;17:1155-1160.
19. Fukunaga M. Flow cytometric and clinicopathologic study of complete hydatidiform moles with special reference to the significance of cytometric aneuploidy. Gynecol Oncol. 2001;81:67-70.
20. Fukunaga M. Immunohistochemical characterization of p57 (KIP2) expression in early hydatidiform moles. Hum Pathol. 2002;33:1188-1192.
21. Fukunaga M. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas. Arch Pathol Lab Med. 2004;128:897-900.
22. Fukunaga M, Katabuchi H, Nagasaka T, et al. Interobserver and intraobserver variability in the diagnosis of hydatidiform mole. Am J Surg Pathol. 2005;29:942-947.
23. Gschwendtner A, Neher A, Kreczy A, et al. DNA ploidy determination of early molar pregnancies by image analysis: comparison to histologic classification. Arch Pathol Lab Med. 1998;122:1000-1004.
24. Hayward BE, De Vos M, Talati N, et al. Genetic and epigenetic analysis of recurrent hydatidiform mole. Hum Mutat. 2009;30:E629-E639.
25. Hoffner L, Dunn J, Esposito N, et al. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum Pathol. 2008;39:63-72.
26. Hoffner L, Parks WT, Swerdlow SH, et al. Simultaneous detection of imprinted gene expression (p57 (KIP2)) and molecular cytogenetics (FICTION) in the evaluation of molar pregnancies. J Reprod Med. 2010;55:219-228.
27. Howat AJ, Beck S, Fox H, et al. Can histopathologists reliably diagnose molar pregnancy? J Clin Pathol. 1993;46:599-602.
28. Javey H, Borazjani G, Behmard S, et al. Discrepancies in the histological diagnosis of hydatidiform mole. Br J Obstet Gynaecol. 1979;86:480-483.
29. Jun. SY, Ro JY, Kim KR. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology. 2003;43:17-25.
30. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet. 2006;43:187-192.
31. Keep D, Zaragoza MV, Hassold T, et al. Very early complete hydatidiform mole. Hum Pathol. 1996;27:708-713.
32. Kerkmeijer LG, Massuger LF, Ten Kate-Booij MJ, et al. Earlier diagnosis and serum human chorionic gonadotropin regression in complete hydatidiform moles. Obstet Gynecol. 2009;113:326-331.
33. Kipp BR, Ketterling RP, Oberg TN, et al. Comparison of fluorescence in situ hybridization, p57 immunostaining, flow cytometry, and digital image analysis for diagnosing molar and nonmolar products of conception. Am J Clin Pathol. 2010;133:196-204.
34. Kou YC, Shao L, Peng HH, et al. A recurrent intragenic genomic duplication, other novel mutations in NLRP7 and imprinting defects in recurrent biparental hydatidiform moles. Mol Hum Reprod. 2008;14:33-40.
35. Lage JM, Mark SD, Roberts DJ, et al. A flow cytometric study of 137 fresh hydropic placentas: correlation between types of hydatidiform moles and nuclear DNA ploidy. Obstet Gynecol. 1992;79:403-410.
36. Lee J, Fung KP. Confidence interval of the kappa coefficient by bootstrap resampling. Psychiatry Res. 1993;49:97-98.
37. LeGallo RD, Stelow EB, Ramirez NC, et al. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization. Am J Clin Pathol. 2008;129:749-755.
38. Lescoat D, Jouan H, Loeuillet-Olivo L, et al. Fluorescent in situ hybridization (FISH) on paraffin-embedded placental tissues as an adjunct for understanding the etiology of early spontaneous abortion. Prenat Diagn. 2005;25:314-317.
39. McConnell TG, Murphy KM, Hafez M, et al. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol. 2009;33:805-817.
40. McConnell TG, Norris-Kirby A, Hagenkord JM, et al. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol. 2009;33:1409-1415.
41. Medeiros F, Callahan MJ, Elvin JA, et al. Intraplacental choriocarcinoma arising in a second trimester placenta with partial hydatidiform mole. Int J Gynecol Pathol. 2008;27:247-251.
42. Merchant SH, Amin MB, Viswanatha DS, et al. p57KIP2 immunohistochemistry in early molar pregnancies: emphasis on its complementary role in the differential diagnosis of hydropic abortuses. Hum Pathol. 2005;36:180-186.
43. Messerli ML, Parmley T, Woodruff JD, et al. Inter-and intrapathologist variability in the diagnosis of gestational trophoblastic neoplasia. Obstet Gynecol. 1987;69:622-626.
44. Murphy KM, McConnell TG, Hafez MJ, et al. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. J Mol Diagn. 2009;11:598-605.
45. Murphy KM, Ronnett BM. Molecular analysis of hydatidiform moles: utilizing p57 immunohistochemistry and molecular genotyping to refine morphologic diagnosis. Pathol Case Rev. 2010;15:126-134.
46. Norris-Kirby A, Hagenkord JM, Kshirsagar MP, et al. Abnormal villous morphology associated with triple trisomy of paternal origin. J Mol Diagn. 2010;12:525-529.
47. Palmieri C, Fisher RA, Sebire NJ, et al. Placental site trophoblastic tumour arising from a partial hydatidiform mole. Lancet. 2005;366:688.
48. Popiolek DA, Yee H, Mittal K, et al. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57 (KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol. 2006;37:1426-1434.
49. Redline RW, Hassold T, Zaragoza M. Determinants of villous trophoblastic hyperplasia in spontaneous abortions. Mod Pathol. 1998;11:762-768.
50. Romaguera RL, Rodriguez MM, Bruce JH, et al. Molar gestations and hydropic abortions differentiated by p57 immunostaining. Fetal Pediatr Pathol. 2004;23:181-190.
51. Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol. 2011;30:101-116.
52. Sarmadi S, Izadi-Mood N, Abbasi A, et al. p57KIP2 immunohistochemical expression: a useful diagnostic tool in discrimination between complete hydatidiform mole and its mimics. Arch Gynecol Obstet. 2011;283:743-748.
53. Sebire NJ, Fisher RA, Foskett M, et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003;110:22-26.
54. Seckl MJ, Fisher RA, Salerno G, et al. Choriocarcinoma and partial hydatidiform moles. Lancet. 2000;356:36-39.
55. Slim R, Mehio A. The genetics of hydatidiform moles: new lights on an ancient disease. Clin Genet. 2007;71:25-34.
56. Sumithran E, Cheah PL, Susil BJ, et al. Problems in the histological assessment of hydatidiform moles: a study on consensus diagnosis and ploidy status by fluorescent in situ hybridisation. Pathology. 1996;28:311-315.
57. Surti U, Hoffner L, Kolthoff M, et al. Persistent gestational trophoblastic disease after an androgenetic/biparental fetal chimera: a case report and review. Int J Gynecol Pathol. 2006;25:366-372.
58. Van de Kaa CA, Robben JC, Hopman AH, et al. Complete hydatidiform mole in twin pregnancy: differentiation from partial mole with interphase cytogenetic and DNA cytometric analyses on paraffin embedded tissues. Histopathology. 1995;26:123-129.
59. Van den Veyver I, Al-Hussaini TK. Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring. Hum Reprod Update. 2006;12:233-242.
60. Wielsma S, Kerkmeijer L, Bekkers R, et al. Persistent trophoblast disease following partial molar pregnancy. Aust N Z J Obstet Gynaecol. 2006;46:119-123.
61. Williams D, Hodgetts V, Gupta J. Recurrent hydatidiform moles. Eur J Obstet Gynecol Reprod Biol. 2010;150:3-7.
62. Yver M, Carles D, Bloch B, et al. Determination of DNA ploidy by fluorescence in situ hybridization (FISH) in hydatidiform moles: evaluation of FISH on isolated nuclei. Hum Pathol. 2004;35:752-758.